rediff.com
e.g. Tata motors, Reliance MF, 500570
Aarti Pharmalabs Ltd. - Research Center
543748 AARTIPHARM Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Half yearly results in brief
(Rs crore)
Sep ' 24 Sep ' 23 Sep ' 22
Sales 770.78 714.28 777.65
Operating profit 168.43 150.55 158.98
Interest 9.64 7.85 9.57
Gross profit 163.84 147.56 150.65
EPS (Rs) 10.48 9.87 10.28
Half yearly  results in details
Sep ' 24 Sep ' 23 Sep ' 22
Other income 5.06 4.86 1.24
Stock adjustment -26.47 -25.40 -73.26
Raw material 387.79 390.52 494.88
Power and fuel - - -
Employee expenses 72.48 61.37 58.33
Excise - - -
Admin and selling expenses - - -
Research and development expenses - - -
Expenses capitalised - - -
Other expenses 168.55 137.24 138.72
Provisions made - - -
Depreciation 37.19 31.76 26.96
Taxation 31.68 26.36 30.50
Net profit / loss 94.98 89.44 93.19
Extra ordinary item - - -
Prior year adjustments - - -
Equity capital 45.31 45.31 45.31
Equity dividend rate - - -
Agg.of non-prom. shares (Lacs) - - -
Agg.of non promotoholding (%) - - -
OPM (%) 21.85 21.08 20.44
GPM (%) 21.12 20.52 19.34
NPM (%) 12.24 12.44 11.96
Close
Add Aarti Pharmalabs Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Aarti Pharmalabs Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close